Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
Clinical trial NCT03767725 · UNKNOWN
Trial details
- NCT number
- NCT03767725
- Sponsor
- Shenzhen Second People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-02
- Primary completion
- 2021-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.